Comparison of somatic variant oncogenicity classification using ClinGen/CGC/VICC guidelines and QIAGEN Clinical Insight Interpret decision support software
Open Access
- 23 September 2025
- journal article
- Published by Elsevier in Cancer Genetics
- Vol. 298-299, 151-158
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)Genetics in Medicine, 2022
- Internal Standardization of the Interpretation and Reporting of Sequence Variants in Hematologic NeoplasmsMolecular Diagnosis & Therapy, 2021
- Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelinesHuman Mutation, 2020
- Predicting Splicing from Primary Sequence with Deep LearningCell, 2019
- Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterionHuman Mutation, 2018
- A Saturation Mutagenesis Approach to Understanding PTEN Lipid Phosphatase Activity and Genotype-Phenotype RelationshipsThe American Journal of Human Genetics, 2018
- A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway AlterationsCancer Cell, 2017
- PERCH: A Unified Framework for Disease Gene PrioritizationHuman Mutation, 2016
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsThe American Journal of Human Genetics, 2016
- Weaver Syndrome‐Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In VitroHuman Mutation, 2015